The Plasma Oxylipin Signature Provides a Deep Phenotyping of Metabolic Syndrome Complementary to the Clinical Criteria - Cnam - Conservatoire national des arts et métiers Access content directly
Journal Articles International Journal of Molecular Sciences Year : 2022

The Plasma Oxylipin Signature Provides a Deep Phenotyping of Metabolic Syndrome Complementary to the Clinical Criteria

Céline Dalle
Jérémy Tournayre
Arne Astrup
André Mazur
Andrzej Szuba
Cécile Gladine

Abstract

Metabolic syndrome (MetS) is a complex condition encompassing a constellation of cardiometabolic abnormalities. Oxylipins are a superfamily of lipid mediators regulating many cardiometabolic functions. Plasma oxylipin signature could provide a new clinical tool to enhance the phenotyping of MetS pathophysiology. A high-throughput validated mass spectrometry method, allowing for the quantitative profiling of over 130 oxylipins, was applied to identify and validate the oxylipin signature of MetS in two independent nested case/control studies involving 476 participants. We identified an oxylipin signature of MetS (coined OxyScore), including 23 oxylipins and having high performances in classification and replicability (cross-validated AUCROC of 89%, 95% CI: 85–93% and 78%, 95% CI: 72–85% in the Discovery and Replication studies, respectively). Correlation analysis and comparison with a classification model incorporating the MetS criteria showed that the oxylipin signature brings consistent and complementary information to the clinical criteria. Being linked with the regulation of various biological processes, the candidate oxylipins provide an integrative phenotyping of MetS regarding the activation and/or negative feedback regulation of crucial molecular pathways. This may help identify patients at higher risk of cardiometabolic diseases. The oxylipin signature of patients with metabolic syndrome enhances MetS phenotyping and may ultimately help to better stratify the risk of cardiometabolic diseases.
Fichier principal
Vignette du fichier
ijms-23-11688-v2.pdf (1.99 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03839966 , version 1 (04-11-2022)

Licence

Attribution

Identifiers

Cite

Céline Dalle, Jérémy Tournayre, Malwina Mainka, Alicja Basiak-Rasała, Mélanie Pétéra, et al.. The Plasma Oxylipin Signature Provides a Deep Phenotyping of Metabolic Syndrome Complementary to the Clinical Criteria. International Journal of Molecular Sciences, 2022, 23 (19), pp.11688. ⟨10.3390/ijms231911688⟩. ⟨hal-03839966⟩
64 View
51 Download

Altmetric

Share

Gmail Facebook X LinkedIn More